|
1.
|
Pollock BE, Jacob JT, Brown PD and
Nippoldt TB: Radiosurgery of growth hormone-producing pituitary
adenomas: factors associated with biochemical remission. J
Neurosurg. 106:833–838. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Rajasoorya C, Holdaway IM, Wrightson P and
Scott DJ: Ibbertson HK determinants of clinical outcome and
survival in acromegaly. Clin Endocrinol. 41:95–102. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Beauregard C, Truong U, Hardy J and Serri
O: Long-term outcome and mortality after transsphenoidal
adenomectomy for acromegaly. Clin Endocrinol. 58:86–91. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Herman V, Fagin J, Gonsky R, Kovacs K and
Melmed S: Clonal origin of pituitary adenomas. J Clin Endocrinol
Metab. 71:1427–1433. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Farrell WE and Clayton RN: Molecular
genetics of pituitary tumours. Trends Endocrinol Metab. 9:20–26.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ezzat S, Kontogeorgos G, Redelmeier DA,
Horvath E, Harris AG and Kovacs K: In vivo responsiveness of
morphological variants of growth hormone-producing pituitary
adenomas to octreotide. Eur J Endocrinol. 133:686–690. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Karga HJ, Alexander JM, Hedley-Whyte ET,
Klibanski A and Jameson JL: Ras mutations in human pituitary
tumors. J Clin Endocrinol Metab. 74:914–919. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Asa SL and Ezzat S: The pathogenesis of
pituitary tumors. Annu Rev Pathol. 4:97–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Mao S and Dong G: Discovery of highly
differentiative gene groups from microarray gene expression data
using the gene club approach. J Bioinform Comput Biol. 3:1263–1280.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Evans CO, Young AN, Brown MR, Brat DJ,
Parks JS, Neish AS and Oyesiku NM: Novel patterns of gene
expression in pituitary adenomas identified by complementary
deoxyribonucleic acid microarrays and quantitative reverse
transcription-polymerase chain reaction. J Clin Endocrinol Metab.
86:3097–3107. 2001.
|
|
11.
|
Morris DG, Musat M, Czirjak S, Hanzely Z,
Lillington DM, Korbonits M and Grossman AB: Differential gene
expression in pituitary adenomas by oligonucleotide array analysis.
Eur J Endocrinol. 153:143–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ellestad LE, Carre W, Muchow M, Jenkins
SA, Wang X, Cogburn LA and Porter TE: Gene expression profiling
during cellular differentiation in the embryonic pituitary gland
using cDNA microarrays. Physiol Genomics. 25:414–425. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Denko N, Schindler C, Koong A, Laderoute
K, Green C and Giaccia A: Epigenetic regulation of gene expression
in cervical cancer cells by the tumor microenvironment. Clin Cancer
Res. 6:480–487. 2000.PubMed/NCBI
|
|
15.
|
Lewis MT: Homeobox genes in mammary gland
development and neoplasia. Breast Cancer Res. 2:158–169. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lappin TR, Grier DG, Thompson A and
Halliday HL: HOX genes: seductive science, mysterious mechanisms.
Ulster Med J. 75:23–31. 2006.PubMed/NCBI
|
|
17.
|
Wang HL, Deng CS, Lin J, Pan DY, Zou ZY
and Zhou XY: Expression of angiopoietin-2 is correlated with
vascularization and tumor size in human colorectal adenocarcinoma.
Tohoku J Exp Med. 213:33–40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Nag S, Nourhaghighi N, Venugopalan R, Asa
SL and Stewart DJ: Angiopoietins are expressed in the normal rat
pituitary gland. Endocr Pathol. 16:67–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Hu B, Guo P, Fang Q, et al: Angiopoietin-2
induces human glioma invasion through the activation of matrix
metalloprotease-2. Proc Natl Acad Sci USA. 100:8904–8909. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Jang TJ, Ji YS and Jung KH: Decreased
expression of 15-hydroxyprostaglandin dehydrogenase in gastric
carcinomas. Yonsei Med J. 49:917–922. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Coggins KG, Latour A, Nguyen MS, Audoly L,
Coffman TM and Koller BH: Metabolism of PGE2 by prostaglandin
dehydrogenase is essential for remodeling the ductus arteriosus.
Nat Med. 8:91–92. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Wolf I, O’Kelly J, Rubinek T, et al:
15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of
human breast cancer. Cancer Res. 66:7818–7823. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Rouault JP, Falette N, Guehenneux F, et
al: Identification of BTG2, an antiproliferative p53-dependent
component of the DNA damage cellular response pathway. Nat Genet.
14:482–486. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Cortes U, Moyret-Lalle C, Falette N, et
al: BTG gene expression in the p53-dependent and -independent
cellular response to DNA damage. Mol Carcinog. 27:57–64. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Farioli-Vecchioli S, Tanori M, Micheli L,
et al: Inhibition of medulloblastoma tumorigenesis by the
antiproliferative and prodifferentiative gene PC3. FASEB J.
21:2215–2225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Subramanian A, Tamayo P, Mootha VK, et al:
Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci
USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Karim R, Tse G, Putti T, Scolyer R and Lee
S: The significance of the Wnt pathway in the pathology of human
cancers. Pathology. 36:120–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Jones SE and Jomary C: Secreted
Frizzled-related proteins: searching for relationships and
patterns. Bioessays. 24:811–820. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Elston MS, Gill AJ, Conaglen JV, et al:
Wnt pathway inhibitors are strongly down-regulated in pituitary
tumors. Endocrinology. 149:1235–1242. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Danen EH and Yamada KM: Fibronectin,
integrins, and growth control. J Cell Physiol. 189:1–13. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Huet C, Pisselet C, Mandon-Pepin B, Monget
P and Monniaux D: Extracellular matrix regulates ovine granulosa
cell survival, proliferation and steroidogenesis: relationships
between cell shape and function. J Endocrinol. 169:347–360. 2001.
View Article : Google Scholar
|
|
32.
|
Paez-Pereda M, Kuchenbauer F, Arzt E and
Stalla GK: Regulation of pituitary hormones and cell proliferation
by components of the extracellular matrix. Braz J Med Biol Res.
38:1487–1494. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Gerger A, Hofmann G, Langsenlehner U, et
al: Integrin alpha-2 and beta-3 gene polymorphisms and colorectal
cancer risk. Int J Colorectal Dis. 24:159–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Sawhney RS, Cookson MM, Omar Y, Hauser J
and Brattain MG: Integrin alpha2-mediated ERK and calpain
activation play a critical role in cell adhesion and motility via
focal adhesion kinase signaling: identification of a novel
signaling pathway. J Biol Chem. 281:8497–8510. 2006. View Article : Google Scholar
|
